Amanda Ang is the Director of Human Health and Potential (HHP) at the National Research Foundation (NRF) Singapore. Amanda is responsible for coordinating across agencies and research institutions to develop and implement strategies to achieve Singapore’s goals of being a leading biomedical hub that transforms and protects health, advances human potential and creates economic value.
Amanda has around 15 years of experience in biomedical healthcare strategy and R&D policy. In the public sector, Amanda was most recently Director of the Health and Biomedical Cluster at the Biomedical Research Council (BMRC), Agency for Science, Technology and Research (ASTAR). In this role, she oversaw the development of research and translational programmes in the biotech, biomanufacturing, precision medicine and medtech fields. She played a leading role to develop Singapore’s Biotech R&D Strategy for RIE2025, under the guidance of the CEO of NRF and the HHP EXCO Chair. As part of this strategy, she managed to secure 10x the funding to greatly expand the size and scope of the Singapore Therapeutics Development Review (STDR), an early-stage translational programme for biotech. Amanda has also held various roles at the Ministry of Trade and Industry (MTI) and ASTAR in R&D policy and planning.
In industry, Amanda has worked at Johnson & Johnson to develop a well-defined government affairs strategy across the pharmaceuticals, medtech and consumer health sectors in Asia Pacific. At Boston Scientific, she held roles in regional marketing, product management and strategy for interventional cardiology and structural heart medical device products, overseeing the marketing and market access needs for the Asia, Middle East and Africa region.
Amanda has a Bachelor of Arts in Biological Sciences from the University of Chicago and an MBA from INSEAD.